Literature DB >> 12874364

Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity.

Simona Stäger1, James Alexander, K Christine Carter, Frank Brombacher, Paul M Kaye.   

Abstract

The roles of interleukin-4 (IL-4) and IL-13 in the regulation of immunity to Leishmania donovani infection are still poorly understood. Here we show that the increased parasite load observed in IL-4(-/-) and IL-4 receptor alpha(-/-) mice correlates with retarded granuloma maturation and antileishmanial activity and that the increased parasite load observed in IL-4 receptor alpha(-/-) mice correlates with increased NOS2 expression and decreased serum gamma interferon levels. IL-4 and IL-13 appear to play little role in regulating collagen deposition in L. donovani-induced granulomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874364      PMCID: PMC166035          DOI: 10.1128/IAI.71.8.4804-4807.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis.

Authors:  J Alexander; K C Carter; N Al-Fasi; A Satoskar; F Brombacher
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

2.  IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis.

Authors:  A C La Flamme; E A Patton; B Bauman; E J Pearce
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

3.  Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis.

Authors:  Elisabeth A Patton; Anne C La Flamme; Joao A Pedras-Vasoncelos; Edward J Pearce
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Authors:  M G Chiaramonte; D D Donaldson; A W Cheever; T A Wynn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 5.  Tissue granuloma structure-function in experimental visceral leishmaniasis.

Authors:  H W Murray
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

6.  Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines.

Authors:  Z Babaloo; P M Kaye; M B Eslami
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

7.  Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.

Authors:  A Satoskar; H Bluethmann; J Alexander
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

Authors:  P M Kaye; A J Curry; J M Blackwell
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production.

Authors:  R Rutschman; R Lang; M Hesse; J N Ihle; T A Wynn; P J Murray
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

10.  The dynamics of granuloma formation in experimental visceral leishmaniasis.

Authors:  M J McElrath; H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  61 in total

1.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.

Authors:  Henry W Murray; Christine W Tsai; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Sex hormones and modulation of immunity against leishmaniasis.

Authors:  Heidi Snider; Claudio Lezama-Davila; James Alexander; Abhay R Satoskar
Journal:  Neuroimmunomodulation       Date:  2009-02-11       Impact factor: 2.492

4.  Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis.

Authors:  R Khatonier; A M Khan; P Sarmah; G U Ahmed
Journal:  J Parasit Dis       Date:  2018-08-22

5.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

6.  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.

Authors:  Asher Maroof; Paul M Kaye
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

7.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.

Authors:  Henry W Murray; Yunhua Zhang; Yan Zhang; Vanitha S Raman; Steven G Reed; Xiaojing Ma
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

8.  A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani.

Authors:  Gaurav Gupta; Kevin J Peine; Dalia Abdelhamid; Heidi Snider; Andrew B Shelton; Latha Rao; Sainath R Kotha; Andrew C Huntsman; Sanjay Varikuti; Steve Oghumu; C Benjamin Naman; Li Pan; Narasimham L Parinandi; Tracy L Papenfuss; A Douglas Kinghorn; Eric M Bachelder; Kristy M Ainslie; James R Fuchs; Abhay R Satoskar
Journal:  ACS Infect Dis       Date:  2015-09-21       Impact factor: 5.084

Review 9.  Cytokines and their STATs in cutaneous and visceral leishmaniasis.

Authors:  Hannah E Cummings; Rashmi Tuladhar; Abhay R Satoskar
Journal:  J Biomed Biotechnol       Date:  2010-03-15

10.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.